MARATTO

article · Advances in clinical and experimental Dentistry/Advances in clinical and experimental Dentistry

Towards a Synergistic Grading System for Mucoepidermoid Carcinoma

20233 citationsOpen accessBadr University in Cairo

Abstract

BackgroundMucoepidermoid carcinoma (MEC) is a diverse salivary gland malignancy with varied prognostic outcomes. Different grading systems have been proposed, each with its complexities and merits. Objective This study harnesses the precision of MEC assessment by consolidating two established grading systems: AFIP and Brandwein. Method We evaluated primary MEC cases (2016-2022) using four prominent grading systems: modified Healey, AFIP, Brandwein, and Katabi. An algorithm was devised to integrate these systems and derive average scores harmoniously. The impact on overall survival, disease-free measures, and recurrence was investigated.Results The integrated grading algorithm yielded a holistic perspective, enhancing the prognostic significance of MEC grading. Brandwein’s high-grade designation emerged as a potent predictor of aggressive behavior. Our approach unveiled nuanced relationships between morphological features and outcomes, offering an avenue for targeted therapeutic decisions.Advances in KnowledgeThis study offers a novel approach to assess MECs—a unified grading system that draws strength from multiple established paradigms. By orchestrating this synergistic approach, clinicians and pathologists can navigate the complexity of MEC with enhanced precision, aiding in prognosis determination and informed therapeutic interventions.

Research topics

  • Salivary Gland Tumors Diagnosis and Treatment

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.21608/aced.2023.232002.1022

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.